Translational Development Acquisition Corp. (TDAC) |
| 10.83 0 (0%) 07-31 16:00 |
| Open: | 10.83 |
| High: | 10.83 |
| Low: | 10.8241 |
| Volume: | 12,913 |
| Market Cap: | 267(M) |
| PE Ratio: | 12.91 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Shell Companies |
| Sector: | Financial Services |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 12.73 |
| Resistance 1: | 10.90 |
| Pivot price: | 10.75 |
| Support 1: | 10.76 |
| Support 2: | 10.67 |
| 52w High: | 10.9 |
| 52w Low: | 10.318 |
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
| EPS | 0.280 |
| Book Value | -0.310 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -0.3 |
| Return on Equity (ttm) | 0.0 |
Sat, 01 Aug 2026
ProLogium And Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment - pulse2.com
Thu, 30 Jul 2026
Translational Development Acquisition Corp. (TDAC) Edges Higher: Stability in a Quiet Market - Volatility Skew - dars.gov.et
Tue, 28 Jul 2026
ProLogium and TDAC (Nasdaq: TDAC) add $50M insider capital for battery SPAC - Stock Titan
Tue, 28 Jul 2026
Translational Development Acquisition, Prologium Secure $50 Million Primary Capital Investment - Moomoo
Tue, 28 Jul 2026
ProLogium and Translational Development Acquisition Corp. - GlobeNewswire
Mon, 27 Jul 2026
Translational Development Acquisition Finalizes $50M PIPE Deal with Naetas Holding Ahead of ProLogium Merger - Kalkine Media
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |